iShares Biotechnology ETF Target of Unusually High Options Trading (NASDAQ:IBB)

iShares Biotechnology ETF (NASDAQ:IBB) was the target of unusually large options trading activity on Tuesday. Stock investors acquired 36,759 put options on the company. This is an increase of 479% compared to the typical volume of 6,354 put options.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock traded down $0.58 during mid-day trading on Tuesday, hitting $147.22. 133,783 shares of the company were exchanged, compared to its average volume of 1,579,979. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.17. The business’s 50 day simple moving average is $141.14 and its two-hundred day simple moving average is $136.77.

Institutional Trading of iShares Biotechnology ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IBB. Future Financial Wealth Managment LLC purchased a new position in shares of iShares Biotechnology ETF during the 1st quarter worth $27,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF during the second quarter worth about $31,000. Pacifica Partners Inc. boosted its stake in iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares during the last quarter. Crewe Advisors LLC grew its holdings in iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares during the period. Finally, YHB Investment Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at about $37,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.